Alpha Tau Medical (DRTS) notice: 20,000 shares from option exercise to be sold

Rhea-AI Filing Summary

Alpha Tau Medical Ltd. files a Form 144 notice for the proposed sale of 20,000 ordinary shares acquired upon exercise of employee stock options on 07/06/2026, with cash payment upon exercise. The filing also lists recent sales by the holder between 06/23/2026 and 07/02/2026, including multiple transactions totaling several blocks of ordinary shares.

Insights

Securities Compliance Analyst

Form 144 notifies of an intended resale of shares obtained by option exercise.

Form 144 is a regulatory notice used to report an intended sale under Rule 144. The filing states 20,000 ordinary shares were acquired upon exercise on 07/06/2026 and are intended to be sold; cash was used to exercise the options.

Timing and sale mechanics are not detailed here; subsequent filings or broker records would show actual sale dates and proceeds.

Equity Capital Markets Specialist

Multiple recent dispositions by the same holder are listed across late June and early July 2026.

The excerpt lists sales on 06/23/2026 (17,500 shares), 06/25/2026 (20,000), 06/30/2026 (20,000), 07/01/2026 (2,127), and 07/02/2026 (17,873). Each row includes gross proceeds in dollars as stated.

These entries are transactional history; whether further resale occurs depends on holder choices and market execution, which are not shown.

Key Figures

Registered for resale: 20,000 shares Sale on 06/23/2026: 17,500 shares Sale on 06/25/2026: 20,000 shares +4 more

7 metrics

Registered for resale 20,000 shares Acquired upon exercise of employee stock options on 07/06/2026

Sale on 06/23/2026 17,500 shares Proceeds listed as $167,051.00

Sale on 06/25/2026 20,000 shares Proceeds listed as $220,004.00

Sale on 06/30/2026 20,000 shares Proceeds listed as $240,044.00

Sale on 07/01/2026 2,127 shares Proceeds listed as $27,691.20

Sale on 07/02/2026 17,873 shares Proceeds listed as $232,397.26

Listing venue Nasdaq Securities noted as Nasdaq-listed in excerpt

Key Terms

employee stock options, Form 144, cash payment upon exercise

3 terms

employee stock options financial

"Shares acquired upon exercise of employee stock options"

Employee stock options are contracts that give workers the right to buy a company's shares at a set price sometime in the future, like a coupon that lets you purchase stock at today’s price later on. Investors care because they align employees’ incentives with company performance and create a potential future claim on shares that can reduce existing owners’ percentage and add to a company’s reported compensation costs.

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

cash payment upon exercise financial

"Cash payment upon exercise of stock options"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/06/2026 - 11:56 AM Accepted by SEC EDGAR 07/06/2026 - 11:55 AM Learn about SEC filing dates

FAQ

What does Alpha Tau Medical (DRTS) Form 144 report?

The filing notifies an intended resale of 20,000 ordinary shares acquired on 07/06/2026 upon exercise of employee stock options, with cash used at exercise. It also lists recent share dispositions by the holder from 06/23/2026 to 07/02/2026.

Who appears to have sold shares in the reported transactions?

The excerpt lists transactions attributed to Levy Raphi with an address fragment and multiple dispositions: 17,500, 20,000, 20,000, 2,127, and 17,873 shares on the dates shown between 06/23/2026 and 07/02/2026.

Does the Form 144 state how the exercised shares were paid for?

Yes. The filing states the 20,000 shares were acquired upon exercise of employee stock options on 07/06/2026 with a cash payment upon exercise as the payment method.

Are the proceeds from the recent sales disclosed in the excerpt?

Yes. Each listed sale row includes dollar amounts next to the share counts, for example $167,051.00 for 17,500 shares on 06/23/2026 and $240,044.00 for 20,000 shares on 06/30/2026, as shown in the excerpt.

Does Form 144 itself complete the sale of shares?

No. Form 144 is a notice of intent to sell under Rule 144; it does not by itself effect a sale. Actual sale execution and settlement details are not provided in the excerpt.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	20000	264600.00	88009737	07/06/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	07/06/2026	Shares acquired upon exercise of employee stock options	Alpha Tau Medical Ltd.			20000	07/06/2026	Cash payment upon exercise of stock options

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Levy Raphi KIRYAT HAMADA 5 JERUSALEM L3 9777605	Ordinary Shares	06/23/2026	17500	167051.00
Levy Raphi KIRYAT HAMADA 5 JERUSALEM L3 9777605	Ordinary Shares	06/25/2026	20000	220004.00
Levy Raphi KIRYAT HAMADA 5 JERUSALEM L3 9777605	Ordinary Shares	06/30/2026	20000	240044.00
Levy Raphi KIRYAT HAMADA 5 JERUSALEM L3 9777605	Ordinary Shares	07/01/2026	2127	27691.20
Levy Raphi KIRYAT HAMADA 5 JERUSALEM L3 9777605	Ordinary Shares	07/02/2026	17873	232397.26

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)